The predictive value of serum mannan-binding lectin levels for diabetic control and renal complications in type 2 diabetic patients

Saudi Medical Journal

Volumn 32, Issue 8, 2011, Pages 784-790

  Elawa, Gamal ^a   Aoudallah, Ahmad M ^a   Hasaneen, Ali E ^a   El Hammady, Amr M ^a  

^a BENHA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CREATININE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MANNAN BINDING LECTIN; UREA; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; MANNOSE BINDING LECTIN;

ARTICLE; CLINICAL ASSESSMENT TOOL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES CONTROL; DIABETIC NEPHROPATHY; DISEASE COURSE; EGYPT; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INFECTIOUS COMPLICATION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; UREA BLOOD LEVEL; BLOOD; INFECTION; METABOLISM;

BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFECTION; MALE; MANNOSE-BINDING LECTIN; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 84856151353     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mohanty P. Glucose challenge stimulates reactive oxygen species generation by leucocytes. J Clin Endocrinol Metab 2000; 85: 2970-2973.
2. Dhindsa S. Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells. Metabolism 2004; 53: 330-334.
3. Digman C, Borto D, Nasraway SA Jr. Hyperglycemia in the critically ill. Nutr Clin Care 2005; 8: 93-101.
4. Walport MJ. Complement: first of two parts. N Engl J Med 2001; 344: 1058-1066.
5. Turner MW, Hamvas RM. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2000; 2: 305-322.
6. Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001; 38: 133-149.
7. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol 2007; 44: 3875-3888.
8. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003; 40: 423-429.
9. Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum Immunol 2006; 67: 247-256.
10. Eisen DP, Stubbs J, Spilsbury D, Carnie J, Leydon J, Howden BP. Low mannose-binding lectin complement activation function is associated with predisposition to Legionnaires' disease. Clin Exp Immunol 2007; 149: 97-102
11. Kinder BW, Van Till JW, Boermeester MA, Modderman PW, Van Sandick JW, Hart MH, et al. Variable mannose-binding lectin expression during postoperative acute-phase response. Surg Infect (Larchmt) 2006; 7: 443-452.
12. Cui YH, Zhang F, Xiong ZG, You XJ, Gao QX, Liu Z. Increased serum complement component 3 and mannose-binding lectin levels in adult Chinese patients with chronic rhinosinusitis. Rhinology 2009; 47: 187-191.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
14. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med Clin (Barc) 2001; 117: 530-533.
15. Eastham R.D, editor. Biochemical Values in Clinical Medicine. 7th ed. Bristol (UK): Wright, Bristol; 1985.
16. Hind CK, Pepys MB. The role of serum C-reactive protein measurement in clinical practice. Int Med 1986; 5: 112-151.
17. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 2001; 167: 2861-2868.
18. Tran CT, Kjeldsen K, Haunsø S, Høiby N, Johansen HK, Christiansen M. Mannan-binding lectin is a determinant of survival in infective endocarditis. Clin Exp Immunol 2007; 148: 101-105.
19. Takahashi K, Chang WC, Takahashi M, Pavlov V, Ishida Y, La Bonte L, et al. Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology 2011; 216: 96-102.
20. Fortpied J, Vertommen D, Van Schaftingen E. Binding of mannose-binding lectin to fructosamines: a potential link between hyperglycaemia and complement activation in diabetes. Diabetes Metab Res Rev 2010; 26: 254-260.
21. Bouwman LH, Eerligh P, Terpstra OT, Daha MR, de Knijff P, Ballieux BE, et al. Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles. Diabetes 2005; 54: 3002-3006.
22. Siassi M, Hohenberger W, Riese J. Mannan-binding lectin (MBL) serum levels and post-operative infections. Biochem Soc Trans 2003; 774: 31-35.
23. Rau BM, Kemppainen EA, Gumbs AA, Büchler MW, Wegscheider K, Bassi C, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg 2007; 245: 745-754.
24. Perez-Castellano M, Peñaranda M, Payeras A, Mile J, Riera M, Vidal J, et al. Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia. Clin Exp Immunol 2006; 145: 228-234.
25. Louropoulou A, van der Velden U, Schoenmaker T, Catsburg A, Savelkoul PH, Loos BG. Mannose-binding lectin gene polymorphisms in relation to periodontitis. J Clin Periodontol 2008; 35: 923-930.
26. Hansen TK, Gall MA, Tarnow L, Thiel S, Stehouwer CD, Schalkwijk CG, et al. Mannose-binding lectin and mortality in type 2 diabetes. Arch Intern Med 2006; 166: 2007-2013.
27. Hansen TK, Gall MA, Tarnow L, Thiel S. Mannose-binding lectin and mortality in patients with type 2 diabetes mellitus-secondary publication. Ugeskr Laeger 2009; 171: 426-429. Danish.
28. Østergaard J, Thiel S, Gadjeva M, Hansen TK, Rasch R, Flyvbjerg A. Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice. Diabetologia 2007; 50: 1541-1549.
29. Hansen TK, Forsblom C, Saraheimo M, Thorn L, Wad J, Høyem P, et al. Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia 2010; 53: 1517-1524.